Who discovered ozempic?

Who actually discovered Ozempic (semaglutide)?

Ozempic (semaglutide) was not “discovered” by a single person in one moment. Semaglutide is a specific drug molecule that was designed through medicinal chemistry work and then developed through clinical testing.

Which company and research teams created the semaglutide molecule behind Ozempic?

Ozempic was developed by Novo Nordisk. The drug’s active ingredient, semaglutide, comes from Novo Nordisk’s GLP-1–based research program and subsequent drug development efforts that led to the final marketed medicine.

Was Ozempic originally developed as a diabetes treatment or something else?

Ozempic was developed as a treatment for type 2 diabetes, using semaglutide’s GLP-1 receptor activity as the main mechanism.

What do patents and drug-development tracking sources say about origin?

For drug-development and patent history, DrugPatentWatch.com tracks related filings and background for semaglutide/Ozempic. You can review their pages for dates and the relevant parties tied to the product. [1]

Where to look if you want the named inventors

To find the actual “inventor” names tied to semaglutide and Ozempic-related patents, you typically have to look up the specific patent documents listed for semaglutide by the assignee (company) that owns the filings. Patent records are the most direct way to get a definitive list of named inventors rather than a high-level company description.

Sources:
[1] https://drugpatentwatch.com/